Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Allogeneic Transplant Can Abrogate the Relapse Risk in the Patients with Detectable Measureable Residual Disease By Multicolor Flow-Cytometry at the Time of Assessment of Acute Myeloid Leukemia Patients in First Remission

Muhned Alhumaid, MD, Georgina S. Daher-Reyes, MD, Arjun Law, MD, Auro Viswabandya, MD, Armin Gerbitz, MD, Fotios Michelis, MD PhD, Igor Nicolas Novitzky-Basso, MDPhDMRCP,FRCPath, Jeffrey H. Lipton, MD PhD, Jonas Mattson, MD PhD, Ivan Pasic, MDPhD, Rajat Kumar, MD, Wilson Lam, MD, Zeyad Al-Shaibani, MD, Hassan Sibai, MBBS, Dennis Dong Hwan Kim, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-136122

Published: 2020

Journal Articles

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 148.

https://doi.org/10.1182/blood-2019-123269

Published: 2019

Journal Articles

Comparison of Mycophenolate Mofetil and a Calcineurin Inhibitor Versus Calcineurin Inhibitor Based Graft-Versus-Host-Disease Prophylaxis for Matched Unrelated Donor Transplant for Acute Myeloid Leukemia. a Study from the ALWP of the EBMT

Annalisa Paviglianiti, MD, Myriam Labopin, MD, Didier Blaise, MD PhD, Gerard Socie, MD PhD, Claude-Eric Bulabois, MD, Celestine Simand, MD, Nathalie Fegueux, MD, Armin Gerbitz, MD, Gaëlle Guillerm, MD, Johan Maertens, Patrice Chevallier, MD, Anne Huynh, MD, Pascal Turlure, MD, Eric Deconinck, MD PhD, Edouard Forcade, MD, Arnon Nagler, MD MSc, Mohamad Mohty, MD PhD

Blood (2019) 134 (Supplement_1): 4548.

https://doi.org/10.1182/blood-2019-122251

Published: 2019

Journal Articles

Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma Improved Overall Survival in Upfront Hematopoietic Stem Cell Transplantation — a Large Retrospective Study By the Chronic Malignancies Working Party of the EBMT

Blood (2018) 132 (Supplement 1): 3464.

https://doi.org/10.1182/blood-2018-99-114402

Published: 2018

Journal Articles

Classification of Donor KIR-Genotype Information to Predict Outcome after Unrelated Hematopoietic Stell Cell Transplantation: The Jury Is Still out

Blood (2018) 132 (Supplement 1): 2162.

https://doi.org/10.1182/blood-2018-99-111242

Published: 2018

Journal Articles

Lenalidomide Enhances MOR202 Dependent Macrophage-Mediated Effector Functions Via the Vitamin D Pathway

Heiko Bruns, PhD, Regina Jitschin, PhDMD, Dimitrios Mougiakakos, Joerg Thomas Bittenbring, MD, Jens Nolting, Maike Büttner, Michael Rehli, PhD, Julia Wimmer, Frank Neumann, PhD, Christian Bach, Heidi Balzer, Stephanie Moi, Peter Brossart, MD, Armin Gerbitz, MD, Andreas Mackensen, MD

Blood (2015) 126 (23): 2203.

https://doi.org/10.1182/blood.V126.23.2203.2203

Published: 2015

Journal Articles

Interleukin-7 Represses the Immunoregulatory Function of Human TCRαβ+ CD4- CD8- Double-Negative (DN) T Cells By Activating Akt/mTOR Signaling

Andrea Allgaeuer, Armin Gerbitz, MD, Andreas Mackensen, MD, Simon Voelkl, PhD

Blood (2014) 124 (21): 4133.

https://doi.org/10.1182/blood.V124.21.4133.4133

Published: 2014

Journal Articles

Transdifferentiation of Malignant B-Cells into Macrophages in a Murine Model of Burkitt´s Lymphoma

Heiko Bruns, PhD, Sebastian Mueller, Christian Bach, Shirin Pasemann, Anna Maurberger, Andreas Mackensen, Armin Gerbitz, MD

Blood (2014) 124 (21): 5406.

https://doi.org/10.1182/blood.V124.21.5406.5406

Published: 2014

Journal Articles

Re-Educating Myeloma Associated Macrophages with Lenalidomide

Heiko Bruns, PhD, Hanna Gehlen, Jens Nolting, Shirin Pasemann, Peter Brossart, MD, Andreas Mackensen, Armin Gerbitz, MD

Blood (2014) 124 (21): 2034.

https://doi.org/10.1182/blood.V124.21.2034.2034

Published: 2014

Journal Articles

Vitamin D-Dependent Induction of Cathelicidin in Human Macrophages Results in Cytotoxicity Against High Grade B-Cell Lymphoma

Heiko Bruns, PhD, Maike Büttner, Mario Fabri, Dimitrios Mougiakakos, Joerg Thomas Bittenbring, MD, Shirin Pasemann, Frank Neumann, Anna Maurberger, Bettina Kempkes, Andreas Mackensen, Armin Gerbitz, MD

Blood (2014) 124 (21): 4108.

https://doi.org/10.1182/blood.V124.21.4108.4108

Published: 2014

Journal Articles

Cathelicidin Mediates Anti Lymphoma Cytotoxicity By Human Macrophages

Heiko Bruns, Mario Fabri, Maike Büttner, Dimitrios Mougiakakos, MD, Shirin Pasemann, Kerstin Amann, Andreas Mackensen, Armin Gerbitz, MD, PhD

Blood (2013) 122 (21): 3458.

https://doi.org/10.1182/blood.V122.21.3458.3458

Published: 2013

Journal Articles

Transdifferentiation Of Malignant B-Cells Into Macrophages In a Murine Model Of Burkitt´s Lymphoma

Heiko Bruns, Sebastian Mueller, Shirin Pasemann, Andreas Mackensen, Armin Gerbitz, MD, PhD

Blood (2013) 122 (21): 1783.

https://doi.org/10.1182/blood.V122.21.1783.1783

Published: 2013

Journal Articles

Vitamin D Triggers Killing of Burkitt Lymphoma Cells by Human Macrophages

Heiko Bruns, Dimitrios Mougiakakos, MD, Mario Fabri, Shirin Pasemann, Regina Jitschin, MD, Kerstin Amann, Maike Büttner, Andreas Mackensen, Armin Gerbitz, MD, PhD

Blood (2012) 120 (21): 1035.

https://doi.org/10.1182/blood.V120.21.1035.1035

Published: 2012

Journal Articles

M1 Macrophages Eliminate Lymphoma Cells Through the Vitamin D Dependent Antimicrobial Peptide Cathelicidin

Heiko Bruns, Mario Fabri, Anna Maurberger, Shirin Pasemann, Cornelia Fahrenwaldt, Andrea Wilke, Stefanie Moi, Heidi Daudt, Kerstin Amann, Maike Büttner, Udo Gaipl, Andreas Mackensen, Armin Gerbitz, MD, PhD

Blood (2011) 118 (21): 1098.

https://doi.org/10.1182/blood.V118.21.1098.1098

Published: 2011

Journal Articles

CD19 as Foreign Antigen Elicits a Specific T-Cell Response and Mediates Rejection of High Grade B-Cell Lymphoma In Mice

Frank Lehmann, Armin Gerbitz, MD, PhD, Christoph Loddenkemper, MD, PhD, Elisabeth Kremmer, PhD, Josef Mautner, PhD, Thomas Kammertöns, PhD, Georg Bornkamm, MD, PhD

Blood (2010) 116 (21): 4907.

https://doi.org/10.1182/blood.V116.21.4907.4907

Published: 2010

Journal Articles

Stromal Cross-Presentation and Host Interferon-γ Signaling and Are Required for Elimination of Antigen-Loss Variants of High-Grade B Cell Lymphomas: Implications for Adoptive T Cell Therapy

Armin Gerbitz, MD, PhD, Madhusudhanan Sukumar, PhD, Florian Helm, Andrea Wilke, Christian Friese, Cornelia Fahrenwaldt, Frank Lehmann, Christoph Loddenkemper, MD, PhD, Thomas Kammertöns, PhD, Josef Mautner, PhD, Thomas Blankenstein, PhD, Georg Bornkamm, MD, PhD

Blood (2010) 116 (21): 3927.

https://doi.org/10.1182/blood.V116.21.3927.3927

Published: 2010

Journal Articles

Tissue Damage and Lymphoma Derived Chemoattractive Signals Impact Regulatory T Cell Trafficking After Allogeneic Hematopoietic Cell Transplantation.

Christoph Dürr, Dietmar Pfeifer, PhD, Annette Schmitt-Gräff, Rainer Claus, Ulrike Gerlach, Ralph Graeser, Armin Gerbitz, MD, Robert Negrin, Jürgen Finke, Robert Zeiser, MD

Blood (2009) 114 (22): 3564.

https://doi.org/10.1182/blood.V114.22.3564.3564

Published: 2009

Journal Articles

The Selenoprotein Thioredoxin Reductase 1 Is Crucial for B-1 Cell but Dispensable for B-2 Cell Development.

Pankaj Kumar Mandal, Ursula Zimber-Strobl, Georg W. Bornkamm, Armin Gerbitz, MD, Marcus Conrad

Blood (2009) 114 (22): 3691.

https://doi.org/10.1182/blood.V114.22.3691.3691

Published: 2009

Journal Articles

Mechanisms of Antigen Dependent and Independent Rejection of High Grade B-Cell Lymphoma in a Murine Model.

Armin Gerbitz, MD, PhD, Madhusudhanan Sukumar, PhD, Florian Helm, Andrea Wilke, Thomas Kammertoens, PhD, Christian Friese, Josef Mautner, PhD, Georg Bornkamm, MD, PhD

Blood (2009) 114 (22): 4091.

https://doi.org/10.1182/blood.V114.22.4091.4091

Published: 2009

Journal Articles

Immunisation against Human c-MYC Elicits a T-Cell Response and Influences Growth of High Grade B-Cell Lymphoma in Mice.

Florian Helm, Andrea Wilke, Thomas Kammertoens, PhD, Christian Friese, Josef Mautner, PhD, Christoph Loddenkemper, MD, PhD, Georg Bornkamm, MD, PhD, Armin Gerbitz, MD, PhD

Blood (2009) 114 (22): 5120.

https://doi.org/10.1182/blood.V114.22.5120.5120

Published: 2009

NARROW

Allogeneic Transplant Can Abrogate the Relapse Risk in the Patients with Detectable Measureable Residual Disease By Multicolor Flow-Cytometry at the Time of Assessment of Acute Myeloid Leukemia Patients in First Remission

Post-Transplant Cyclophosphamide Versus Antithymocyte Globulin in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation from HLA-Identical Sibling Donors: A Retrospective Analysis from the Acute Leukemia Working Party of the EBMT

Comparison of Mycophenolate Mofetil and a Calcineurin Inhibitor Versus Calcineurin Inhibitor Based Graft-Versus-Host-Disease Prophylaxis for Matched Unrelated Donor Transplant for Acute Myeloid Leukemia. a Study from the ALWP of the EBMT

Treosulfan Conditioning for Allogeneic Transplantation in Multiple Myeloma Improved Overall Survival in Upfront Hematopoietic Stem Cell Transplantation — a Large Retrospective Study By the Chronic Malignancies Working Party of the EBMT

Classification of Donor KIR-Genotype Information to Predict Outcome after Unrelated Hematopoietic Stell Cell Transplantation: The Jury Is Still out

Lenalidomide Enhances MOR202 Dependent Macrophage-Mediated Effector Functions Via the Vitamin D Pathway

Interleukin-7 Represses the Immunoregulatory Function of Human TCRαβ+ CD4- CD8- Double-Negative (DN) T Cells By Activating Akt/mTOR Signaling

Transdifferentiation of Malignant B-Cells into Macrophages in a Murine Model of Burkitt´s Lymphoma

Re-Educating Myeloma Associated Macrophages with Lenalidomide

Vitamin D-Dependent Induction of Cathelicidin in Human Macrophages Results in Cytotoxicity Against High Grade B-Cell Lymphoma

Cathelicidin Mediates Anti Lymphoma Cytotoxicity By Human Macrophages

Transdifferentiation Of Malignant B-Cells Into Macrophages In a Murine Model Of Burkitt´s Lymphoma

Vitamin D Triggers Killing of Burkitt Lymphoma Cells by Human Macrophages

M1 Macrophages Eliminate Lymphoma Cells Through the Vitamin D Dependent Antimicrobial Peptide Cathelicidin

CD19 as Foreign Antigen Elicits a Specific T-Cell Response and Mediates Rejection of High Grade B-Cell Lymphoma In Mice

Stromal Cross-Presentation and Host Interferon-γ Signaling and Are Required for Elimination of Antigen-Loss Variants of High-Grade B Cell Lymphomas: Implications for Adoptive T Cell Therapy

Tissue Damage and Lymphoma Derived Chemoattractive Signals Impact Regulatory T Cell Trafficking After Allogeneic Hematopoietic Cell Transplantation.

The Selenoprotein Thioredoxin Reductase 1 Is Crucial for B-1 Cell but Dispensable for B-2 Cell Development.

Mechanisms of Antigen Dependent and Independent Rejection of High Grade B-Cell Lymphoma in a Murine Model.

Immunisation against Human c-MYC Elicits a T-Cell Response and Influences Growth of High Grade B-Cell Lymphoma in Mice.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only